These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33081037)

  • 1. Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R).
    Rossino G; Rui M; Pozzetti L; Schepmann D; Wünsch B; Zampieri D; Pellavio G; Laforenza U; Rinaldi S; Colombo G; Morelli L; Linciano P; Rossi D; Collina S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.
    Rui M; Rossino G; Coniglio S; Monteleone S; Scuteri A; Malacrida A; Rossi D; Catenacci L; Sorrenti M; Paolillo M; Curti D; Venturini L; Schepmann D; Wünsch B; Liedl KR; Cavaletti G; Pace V; Urban E; Collina S
    Eur J Med Chem; 2018 Oct; 158():353-370. PubMed ID: 30223122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel High Affinity Sigma-1 Receptor Ligands from Minimal Ensemble Docking-Based Virtual Screening.
    Dvorácskó S; Lázár L; Fülöp F; Palkó M; Zalán Z; Penke B; Fülöp L; Tömböly C; Bogár F
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands.
    Zampieri D; Calabretti A; Romano M; Fortuna S; Collina S; Amata E; Dichiara M; Marrazzo A; Mamolo MG
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents.
    Linciano P; Sorbi C; Rossino G; Rossi D; Marsala A; Denora N; Bedeschi M; Marino N; Miserocchi G; Dondio G; Peviani M; Tesei A; Collina S; Franchini S
    Eur J Med Chem; 2023 Mar; 249():115163. PubMed ID: 36716640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands.
    Elkholy N; Abdelwaly A; Mohamed K; Amata E; Lombino J; Cosentino G; Intagliata S; Helal MA
    Chem Biol Drug Des; 2022 Jul; 100(1):25-40. PubMed ID: 35353926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
    Zampieri D; Fortuna S; Calabretti A; Romano M; Menegazzi R; Schepmann D; Wünsch B; Collina S; Zanon D; Mamolo MG
    Eur J Med Chem; 2019 Oct; 180():268-282. PubMed ID: 31319263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands.
    Peng Y; Dong H; Welsh WJ
    J Chem Inf Model; 2019 Jan; 59(1):486-497. PubMed ID: 30497261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative.
    Rossino G; Orellana I; Caballero J; Schepmann D; Wünsch B; Rui M; Rossi D; González-Avendaño M; Collina S; Vergara-Jaque A
    J Chem Inf Model; 2020 Feb; 60(2):756-765. PubMed ID: 31809025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines.
    Rossi D; Rui M; Di Giacomo M; Schepmann D; Wünsch B; Monteleone S; Liedl KR; Collina S
    Bioorg Med Chem; 2017 Jan; 25(1):11-19. PubMed ID: 27838169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands.
    Donnier-Maréchal M; Carato P; Larchanché PE; Ravez S; Boulahjar R; Barczyk A; Oxombre B; Vermersch P; Melnyk P
    Eur J Med Chem; 2017 Sep; 138():964-978. PubMed ID: 28756263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma-1 Receptor Agonists Acting on Aquaporin-Mediated H
    Pellavio G; Rossino G; Gastaldi G; Rossi D; Linciano P; Collina S; Laforenza U
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization.
    Rossino G; Rui M; Linciano P; Rossi D; Boiocchi M; Peviani M; Poggio E; Curti D; Schepmann D; Wünsch B; González-Avendaño M; Vergara-Jaque A; Caballero J; Collina S
    J Med Chem; 2021 Oct; 64(20):14997-15016. PubMed ID: 34624193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
    Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma.
    Mysona B; Kansara N; Zhao J; Bollinger K
    Adv Exp Med Biol; 2017; 964():299-307. PubMed ID: 28315279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders.
    Maurice T
    Expert Opin Drug Discov; 2021 Apr; 16(4):373-389. PubMed ID: 33070647
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are sigma receptor modulators a weapon against multiple sclerosis disease?
    Collina S; Rui M; Stotani S; Bignardi E; Rossi D; Curti D; Giordanetto F; Malacrida A; Scuteri A; Cavaletti G
    Future Med Chem; 2017 Nov; 9(17):2029-2051. PubMed ID: 29076758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma Receptor Binding Assays.
    Chu UB; Ruoho AE
    Curr Protoc Pharmacol; 2015 Dec; 71():1.34.1-1.34.21. PubMed ID: 26646191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.